Parameter | Value |
---|---|
Gene | Tp53 |
Protein Name | P53_MOUSE |
Organism | Mus musculus (Mouse) |
Alternative name(s) | Cellular tumor antigen p53 (Tumor suppressor p53) |
Protein Family | P53 family |
NCBI Gene ID | 22059 |
UniProt ID | P02340 |
Enzyme Class | - |
Molecular Weight | 43458 |
Protein Length | 390 |
Protein Domain | InterPro | Pfam |
3D Structure |
PDBe |
PDBj |
RCSB PDB |
DrugPort
ModBase | SwissModel |
Gene Expression | Gene Expression Atlas |
Function and Disease | OMIM |
Protein-protein Interaction Database | STRING | IntAct | MINT |
Kinase Database | Phospho.ELM | PhosphoSite | NetworKIN |
Catalytic Activity (UniProt annotation) | - |
Localization | Cytoplasm |
Function (UniProt annotation) | Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression (By similarity). Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis, but seems to have to effect on cell-cycle regulation. Regulates the circadian clock by repressing CLOCK-ARNTL/BMAL1-mediated transcriptional activation of PER2 (PubMed:24051492). |
Gene Ontology | GO:0000060; GO:0000122; GO:0000733; GO:0000785; GO:0000790; GO:0000977; GO:0000978; GO:0000980; GO:0000981; GO:0001046; GO:0001074; GO:0001077; GO:0001085; GO:0001094; GO:0001221; GO:0001228; GO:0001701; GO:0001756; GO:0001836; GO:0002020; GO:0002039; GO:0002309; GO:0002326; GO:0002360; GO:0002687; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0003730; GO:0005507; GO:0005524; GO:0005622; GO:0005634; GO:0005654; GO:0005657; GO:0005667; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0005783; GO:0005829; GO:0006289; GO:0006302; GO:0006355; GO:0006357; GO:0006914; GO:0006915; GO:0006974; GO:0006977; GO:0006978; GO:0006979; GO:0006983; GO:0007050; GO:0007179; GO:0007275; GO:0007369; GO:0007406; GO:0007417; GO:0007507; GO:0007569; GO:0007623; GO:0008022; GO:0008104; GO:0008134; GO:0008156; GO:0008285; GO:0008340; GO:0009299; GO:0009303; GO:0009411; GO:0009651; GO:0009792; GO:0010165; GO:0010332; GO:0010628; GO:0010629; GO:0010666; GO:0016032; GO:0016363; GO:0016605; GO:0019899; GO:0019901; GO:0019903; GO:0021549; GO:0030308; GO:0030330; GO:0030512; GO:0030971; GO:0031065; GO:0031497; GO:0031571; GO:0031625; GO:0032461; GO:0032991; GO:0033077; GO:0034103; GO:0034613; GO:0034614; GO:0034644; GO:0035033; GO:0035035; GO:0035264; GO:0035794; GO:0035861; GO:0036003; GO:0042127; GO:0042149; GO:0042493; GO:0042771; GO:0042802; GO:0042826; GO:0042981; GO:0043065; GO:0043066; GO:0043153; GO:0043504; GO:0043516; GO:0043523; GO:0043525; GO:0043565; GO:0043621; GO:0044212; GO:0045787; GO:0045861; GO:0045892; GO:0045893; GO:0045899; GO:0045930; GO:0045944; GO:0046982; GO:0047485; GO:0048147; GO:0048512; GO:0048568; GO:0048662; GO:0050731; GO:0050821; GO:0051087; GO:0051276; GO:0051289; GO:0051402; GO:0051453; GO:0051721; GO:0051726; GO:0051974; GO:0060333; GO:0060411; GO:0061419; GO:0065003; GO:0070059; GO:0070243; GO:0070245; GO:0070266; GO:0071158; GO:0071479; GO:0071480; GO:0071494; GO:0071850; GO:0072331; GO:0072332; GO:0072363; GO:0072717; GO:0090200; GO:0090343; GO:0090399; GO:0090403; GO:0097252; GO:0097371; GO:0097718; GO:1900119; GO:1901525; GO:1902108; GO:1902253; GO:1902895; GO:1903205; GO:1903799; GO:1903800; GO:1904024; GO:1990144; GO:1990440; GO:1990841; GO:2000269; GO:2000279; GO:2000378; GO:2000379; GO:2000772; GO:2001244 |
Gene Name | Organism | P-Site | Sequence(+/-7) | Conservation | Disorder | Curator Assessment | Reliability | Evidence Class | Evidence Logic | PubMed | Phospho-ELM | PhosphoSite-Plus |
---|---|---|---|---|---|---|---|---|---|---|---|---|
PRKAA2 (P54646) | Homo sapiens | S18 | ISLELPLSQETFSGL | N/A | 0.3053 | - | - | - | - | - | - |
|
Reactome Pathways
KEGG Pathways
No NCI Nature pathways found